What Does a Public Health Emergency Declaration Do?

Last updated 4 months ago. Our resources are updated regularly but please keep in mind that links, programs, policies, and contact information do change.

When the U.S. government confronts a major health threat—from a fast-moving pandemic like COVID-19 to a slow-burning crisis like the opioid epidemic—it can declare a Public Health Emergency (PHE).

This formal declaration signals that a health crisis has reached a level of severity requiring a national response. But what does this declaration actually do?

The Legal Foundation

The legal bedrock for a federal Public Health Emergency declaration is Section 319 of the Public Health Service Act. This statute grants the Secretary of the Department of Health and Human Services the authority to determine that an emergency exists.

The law provides the Secretary with significant discretion, outlining two broad conditions for a declaration: first, that a specific “disease or disorder presents a public health emergency,” or second, that “a public health emergency, including significant outbreaks of infectious diseases or bioterrorist attacks, otherwise exists.”

The process for making this determination is relatively streamlined. The HHS Secretary must consult with public health officials as deemed necessary, but a crucial feature of the law is that it does not require a formal request from a state or local government. This empowers the federal government to act proactively when a health threat emerges that may cross state lines or overwhelm regional capabilities.

Who Declares It and For How Long?

The authority to declare a PHE rests exclusively with the Secretary of HHS. This cabinet-level official is responsible for assessing the public health landscape and making the final determination.

A PHE declaration is not open-ended. By law, it has a specific and limited lifespan. A declaration lasts for the duration of the emergency or for 90 days, whichever comes first. This 90-day clock provides a built-in mechanism for regular review and prevents emergency powers from extending indefinitely without reassessment.

However, for long-term, persistent crises, this is not a hard stop. The law explicitly allows the Secretary to renew the declaration for subsequent 90-day periods as long as the underlying emergency conditions continue to exist. This renewal authority has been critical in sustaining the federal response to chronic emergencies like the opioid crisis.

To ensure legislative oversight and inter-agency coordination, the Secretary is required to provide written notification to Congress no later than 48 hours after making a PHE determination, including any renewals. Relevant federal agencies, such as the Department of Homeland Security and the Department of Justice, must also be kept informed.

Powers Unlocked by a PHE Declaration

Declaring a PHE does not automatically trigger a single, monolithic response. Instead, it unlocks a diverse toolkit of potential authorities, funding mechanisms, and regulatory flexibilities that the HHS Secretary can choose to deploy based on the specific needs of the crisis.

These powers are discretionary, not mandatory.

Financial Flexibility and Funding Streams

While a PHE declaration is often perceived as releasing a flood of new money, the reality is more complex. The declaration primarily provides access to pre-existing, but often unfunded, financial mechanisms and allows for greater flexibility in the use of existing grant money.

The Public Health Emergency Fund: The law establishes a dedicated “Public Health Emergency Fund” in the U.S. Treasury. This is a “no-year” fund, meaning any money appropriated to it does not expire at the end of a fiscal year, allowing for a ready reserve.

A PHE declaration is the key that allows the Secretary to access these funds to make grants, enter into contracts, and support investigations. However, this legal authority is only as powerful as the money Congress chooses to put into the fund.

Analysis reveals a critical disconnect between this legal authority and financial reality. The Government Accountability Office has reported that the fund has not received any new appropriations from Congress in over 25 years. This makes it a “zombie fund”—an entity that exists in law but lacks the resources to act independently.

The 2017 opioid PHE declaration came with the explicit clarification that “no additional federal funds will be released.” This demonstrates that a PHE declaration is not a blank check—significant funding for a response must come from other sources, such as existing agency budgets or separate congressional appropriations.

Infectious Diseases Rapid Response Reserve Fund: For crises involving infectious diseases, a PHE can also enable the Director of the Centers for Disease Control and Prevention to access this separate, specialized fund, when it has been appropriated by Congress.

Regulatory Waivers: The Section 1135 “Super-Waiver”

Perhaps the most significant operational power unlocked by a PHE is the authority to grant regulatory flexibility, allowing the massive and often rigid U.S. healthcare system to become more agile. The primary tool for this is Section 1135 of the Social Security Act.

A PHE declaration is a prerequisite for the HHS Secretary to invoke Section 1135, which grants the authority to temporarily waive or modify a wide range of federal requirements for major healthcare programs, including Medicare, Medicaid, the Children’s Health Insurance Program, and HIPAA.

These waivers are designed to ensure that sufficient healthcare services remain available during an emergency.

However, there is a critical and often misunderstood caveat: activating these powerful “1135 waivers” requires a dual declaration. The HHS Secretary cannot act alone. There must be both a PHE declaration from HHS and a separate emergency or disaster declaration from the President under either the Stafford Act or the National Emergencies Act.

This “dual-key” system serves as a check and balance, ensuring that sweeping changes to major entitlement programs have agreement at the highest levels of both HHS and the White House.

When this dual-key condition is met, the Secretary can authorize waivers such as:

Provider Licensing: Waiving requirements that physicians and other healthcare professionals be licensed in the state where they provide services, as long as they have an equivalent license in another state.

Conditions of Participation: Temporarily modifying or waiving certain hospital and provider requirements for Medicare and Medicaid to allow for surge capacity and flexible operations.

Sanction Waivers: Waiving sanctions under emergency treatment laws to allow hospitals to redirect patients for screening, and under physician self-referral laws to remove obstacles to referrals needed during an emergency.

HIPAA Privacy Rule: Relaxing certain provisions to facilitate communication with family members and the sharing of patient information necessary for care coordination.

Personnel and Resource Deployment

A PHE declaration gives the Secretary several tools to rapidly mobilize human resources and physical assets.

Temporary Hiring: The Secretary can make temporary appointments of personnel for up to one year to positions that directly respond to the emergency, bypassing the lengthy standard competitive hiring process to fill critical roles quickly.

Reassignment of State and Local Personnel: The Secretary can authorize a state’s Governor or a tribal organization to temporarily reassign state and local public health personnel whose salaries are funded in whole or in part by federal programs.

Direct Support to Grantees: HHS can directly support its partners by detailing federal employees or providing supplies, equipment, and services to an entity that has received a grant or contract, in lieu of a portion of their monetary award.

Streamlining the Response

Beyond funding and personnel, a PHE declaration helps cut through red tape that could otherwise slow down an effective response.

Data and Reporting Waivers: The Secretary can grant extensions or waive penalties for public or private entities that are unable to meet deadlines for submitting data or reports required under HHS-administered laws due to the emergency.

The 21st Century Cures Act added a provision allowing the Secretary to waive requirements of the Paperwork Reduction Act for voluntary information collection needed for an immediate investigation—a power used during the opioid crisis.

Procurement and Supplies: The declaration allows state, local, and tribal governments to access the General Services Administration Federal Supply Schedule when using federal grant funds. This greatly streamlines the process of purchasing essential supplies from pre-vetted federal contractors.

Drug Pricing and Access: In situations where a PHE causes drug shortages and sudden price spikes, the Secretary has the authority to adjust Medicare Part B drug reimbursement to ensure payments more accurately reflect current market prices, protecting access for beneficiaries.

Liability Protections: A PHE declaration is often a necessary predicate for the Secretary to issue a declaration under the Public Readiness and Emergency Preparedness (PREP) Act. A PREP Act declaration provides broad liability immunity to manufacturers, distributors, and administrators of critical medical countermeasures—such as vaccines, therapeutics, and diagnostic tests—used to combat the public health threat.

Not All Emergencies Are Created Equal

The federal government possesses a diversified toolkit for responding to crises, and a Public Health Emergency under the Public Health Service Act is just one of several distinct legal instruments.

Understanding the differences between these declarations is essential for grasping the nature and scope of a federal response, as the choice of which tool to use is a strategic decision that shapes the entire effort.

PHE vs. The Stafford Act: Health Crisis vs. Natural Disaster

The two most significant and commonly used federal emergency frameworks are the PHE declaration and a declaration under the Robert T. Stafford Disaster Relief and Emergency Assistance Act. They are often confused but serve fundamentally different purposes.

Public Health Service Act (PHE): A PHE is a health-focused instrument. Declared solely by the HHS Secretary without needing a state request, it is triggered by a disease, disorder, or other threat to public health.

Its powers are tailored to the healthcare system: unlocking regulatory waivers for Medicare and Medicaid, enabling the deployment of specialized health personnel, and providing liability protections for medical countermeasures. The response is led by HHS and its operational divisions, like the Administration for Strategic Preparedness and Response and the CDC.

Stafford Act (Major Disaster or Emergency): A Stafford Act declaration is the federal government’s primary tool for all-hazards disaster relief. It is declared by the President, almost always following a formal request from a state’s governor or a tribal chief executive.

Its triggers are traditionally catastrophic physical events: hurricanes, floods, earthquakes, or large-scale explosions. The powers it unlocks are primarily financial and logistical, providing massive federal assistance through the Disaster Relief Fund.

This includes Public Assistance to rebuild damaged infrastructure and Individual Assistance to help citizens with housing and other personal needs. The entire response is coordinated by FEMA.

The COVID-19 pandemic provided the ultimate case study in how these tools can be used concurrently. The HHS Secretary declared a PHE on January 31, 2020, to enable health-specific actions like developing tests and vaccines and preparing for regulatory waivers.

Then, on March 13, 2020, the President declared a Stafford Act emergency, unlocking FEMA’s immense logistical power and financial resources to supplement the health response. This provided states with a 75% federal cost-share for activities like activating emergency operations centers and deploying the National Guard.

A significant development has been the evolving interpretation of what constitutes a “disaster.” The Stafford Act’s definition of a “major disaster” does not explicitly list infectious diseases. Historically, public health incidents like the West Nile Virus outbreak received only the lesser “emergency declarations” under the Act.

The COVID-19 pandemic marked a landmark shift, becoming the first time that “major disaster declarations” were issued for an infectious disease. This has set a powerful new precedent, potentially blurring the traditional lines between HHS and FEMA.

The National Emergencies Act: The Third Path

A third, distinct authority is the National Emergencies Act. When the President declares a national emergency under this act, it does not grant any specific powers on its own. Instead, it functions like a master switch, activating a variety of standby emergency authorities contained in other statutes.

The President’s declaration must specify which of these other statutory powers are being activated. It is a different and less frequently used mechanism for public health crises compared to the Public Health Service and Stafford Acts.

State and Local Powers: The Foundation

It’s essential to recognize that the federal response is designed to supplement, not supplant, the efforts of state, local, and tribal governments, which are the primary responders in any crisis.

Every state grants its governor the authority to declare a state of emergency via executive order. Such a declaration can activate state emergency response plans, waive or suspend state-level rules and regulations, and deploy state-controlled resources, including the National Guard.

Furthermore, the legal landscape is layered. Many states have also passed laws that specifically empower their state health officer or agency director to declare a public health emergency, which may have different triggers or unlock different powers than a gubernatorial declaration.

Case Study: The U.S. Opioid Crisis Public Health Emergency

To understand what a PHE declaration does in practice—especially for a chronic, rather than acute, crisis—there is no better case study than the U.S. opioid epidemic. The application of this emergency tool to a deeply entrenched societal problem reveals both its utility and its profound limitations.

The Path to Declaration

The decision to declare a PHE in 2017 was the culmination of a crisis that had been building for decades across three distinct and devastating waves.

The first wave began in the 1990s with a surge in the prescribing of opioid pain relievers, leading to widespread misuse and a steady rise in overdose deaths.

The second wave began around 2010, marked by a rapid increase in deaths involving heroin as some individuals with opioid use disorder transitioned from prescription pills to the cheaper, more potent illicit drug.

The third and most lethal wave began in 2013 with the proliferation of illicitly manufactured synthetic opioids, particularly fentanyl, which is 50 to 100 times more potent than morphine and began to contaminate the entire illicit drug supply.

By 2016, the death toll had become staggering, with over 42,000 Americans dying from opioid-involved overdoses. HHS officials cited the relentlessly increasing rates of death and opioid use disorder as the primary factors driving the need for a national declaration.

On October 26, 2017, following a directive from the President, Acting HHS Secretary Eric D. Hargan officially declared the opioid crisis a nationwide Public Health Emergency—the first time such a declaration had ever been made for this issue.

Timeline of the Opioid PHE

The declaration for the opioid crisis has been continuously renewed every 90 days since its inception, underscoring the chronic and persistent nature of the epidemic. This stands in contrast to the acute, short-term emergencies the law was originally envisioned to address.

Powers Invoked: What Did the Opioid PHE Actually Do?

Despite the vast toolkit of powers available under a PHE, the federal government’s use of these authorities for the opioid crisis was remarkably targeted and limited. The response was not a sweeping mobilization but a focused effort to reduce specific administrative burdens and enhance data collection.

This reveals a fundamental point: a PHE declaration is not a panacea. Applying an “emergency” framework designed for hurricanes or pandemics to a deeply entrenched societal problem like addiction demonstrates the limits of such legal instruments.

The Game Changer: Telemedicine Expansion

The single most significant and widely cited action facilitated by emergency declarations was the dramatic expansion of telemedicine for substance use disorder treatment.

The primary barrier to this was the Ryan Haight Online Pharmacy Consumer Protection Act of 2008, which generally requires a provider to conduct an in-person medical evaluation before prescribing a controlled substance via telemedicine.

During the public health emergencies, the DEA, in conjunction with HHS, used the emergency authority to grant flexibilities to this rule. This allowed qualified practitioners to prescribe essential medications for opioid use disorder, such as buprenorphine, to patients via audio-visual and, in some cases, audio-only telehealth appointments without a prior in-person visit.

This was a monumental shift that removed a major obstacle to care, especially for individuals in rural areas or those with transportation challenges. The value of this flexibility was deemed so high that even after the COVID-19 PHE ended, the DEA issued multiple temporary extensions of these rules through December 31, 2025.

Enhancing Public Health Surveillance

A second key area of action was improving the collection and use of data to better understand and respond to the epidemic. The PHE helped facilitate and underscore the urgency of these efforts.

Overdose Data to Action (OD2A): This flagship CDC program was a central part of the surveillance response. OD2A is a cooperative agreement providing funding to state, territorial, and local health departments to collect more timely and comprehensive data on both fatal and nonfatal overdoses.

Modernizing Data Systems: The PHE context supported projects to modernize the nation’s vital statistics infrastructure. This included enhancing the National Vital Statistics System to improve the quality, timeliness, and geographic detail of opioid-related mortality data.

Data Sharing and Mapping: Other initiatives supported under the PHE included the Comprehensive Opioid, Stimulant, and Substance Use Program and the Overdose Detection Mapping Application Program, which help public health and public safety officials share data to identify overdose hotspots.

The Few Other Authorities Used

A comprehensive review by the Government Accountability Office in the early stages of the opioid PHE found that the federal government had used only three of the available authorities in a meaningful way:

Paperwork Reduction Act Waiver: HHS used this authority to bypass the standard, lengthy approval process for a federal survey. This allowed the agency to quickly field a survey to over 13,000 healthcare providers to assess their buprenorphine prescribing practices and identify barriers.

Temporary Reassignment of Personnel: The declaration provided the authority to temporarily detail federal personnel to focus on the opioid crisis.

Expedited State Medicaid Demonstrations: HHS leveraged the PHE to waive the standard public notice and comment periods for two state Medicaid demonstration projects focused on substance use disorder treatment.

Crucially, the GAO report noted that according to HHS officials, many of the other powers available under a PHE—such as those related to emergency procurement or deploying medical teams—were determined to be “not relevant to the circumstances presented by the opioid crisis.”

Impact Assessment: Successes and Limitations

Evaluating the effectiveness of the opioid PHE requires a sober, balanced assessment that acknowledges modest successes while confronting the grim reality of a crisis that continued to deepen.

The declaration was a single tool applied to a multi-faceted problem with roots stretching back decades, and its impact must be understood within that broader context.

Measuring Progress

Since the 2017 declaration, there have been measurable areas of progress in the federal response, though these are juxtaposed with the continued, devastating loss of life.

Positive Trends: On the prevention front, there has been remarkable success in curbing the overprescribing of opioids that fueled the first wave of the epidemic. Between 2011 and 2020, opioid prescribing nationwide fell by 44.4%.

On the treatment front, efforts to expand the workforce were successful, with the number of providers obtaining a federal waiver to prescribe buprenorphine increasing significantly. Furthermore, academic research found that in states that expanded Medicaid under the Affordable Care Act, there was an associated 6% reduction in total opioid overdose deaths compared to non-expansion states.

Persistent Crisis: Despite these positive steps, the overall crisis worsened dramatically after 2017. The primary driver was the third wave of the epidemic: the flood of illicitly manufactured fentanyl.

Overdose deaths, which stood at around 70,000 in 2017, surged during the COVID-19 pandemic, surpassing a grim milestone of 100,000 annually. While provisional data for 2023 showed a slight decline, the death toll remains tragically high, with nearly 80,000 opioid-involved deaths.

Overdose Deaths During the PHE Era

This table provides the stark numerical context for the entire crisis, showing the trajectory of deaths before and during the Public Health Emergency.

The Limits of Emergency Powers

The opioid PHE was not a silver bullet because it could not address the deep, systemic issues at the heart of the crisis. Its limitations reveal why such a declaration can only be one small part of a much larger, long-term strategy.

The Funding Reality: As established, the PHE declaration itself did not unlock a significant new stream of federal dollars. The billions of dollars that flowed to states to combat the crisis came from separate, specific congressional actions, most notably through the State Opioid Response and Tribal Opioid Response grant programs administered by SAMHSA.

Persistent Regulatory Barriers: The PHE could not unilaterally fix long-standing regulatory barriers that impede access to care.

Methadone’s “Handcuffs”: Methadone is a highly effective, life-saving medication for opioid use disorder. Yet, federal law dating back to the 1970s restricts its dispensing for addiction treatment to specialized, highly regulated Opioid Treatment Programs.

These facilities are scarce—located in only 5% of U.S. zip codes—and often require patients to make daily visits, an immense burden that creates a major barrier to treatment. A PHE declaration could not change this fundamental statutory limitation.

Provider Hesitancy and Workforce Gaps: While the federal government eventually removed the “X-waiver” requirement to prescribe buprenorphine, this only addressed the legal ability to prescribe, not the willingness. Many providers remain hesitant due to concerns about inadequate reimbursement, lack of institutional support, stigma, and fear of increased DEA scrutiny.

Harm Reduction Hurdles: Access to proven harm reduction tools remains patchy. The recent FDA approval of over-the-counter naloxone is a positive step, but its cost can be a barrier. More critically, fentanyl test strips, which can help users identify the presence of the deadly synthetic opioid, remain illegal under drug paraphernalia laws in many states.

A Crisis Decades in the Making

The PHE was a response to a crisis whose seeds were sown decades earlier, partly through regulatory failures. Critics point to the FDA’s actions in the 1990s and 2000s, such as approving new opioids with overly broad indications for use, failing to require drug companies to produce adequate evidence of their long-term safety and effectiveness for chronic pain, and failing to properly manage conflicts of interest.

These historical failures created the conditions for the epidemic to take root, a problem far too deep to be solved by a later emergency declaration.

Human Impact and Community Voices

Behind the statistics and policy debates lies a landscape of human devastation. The opioid crisis has inflicted a profound and unequal toll on American communities, a reality that abstract policy discussions can obscure.

Disproportionate Impact

The crisis has hit certain populations with particular intensity. Justice-involved individuals have significantly higher rates of opioid use disorder and face enormous barriers to accessing treatment upon release from jail or prison, a period of extremely high risk for fatal overdose.

Rural communities, often struggling with economic decline and a shortage of healthcare providers, have also been disproportionately affected.

The Ripple Effect on Families

The impact ripples outward from the individual, devastating families and communities. The crisis has been linked to a rise in the number of children entering the foster care system and an increase in neonatal abstinence syndrome in newborns.

The trauma of having a parent with opioid use disorder or losing a family member to overdose has a measurable negative impact on the educational outcomes and mental health of children, creating cycles of disadvantage.

One public health official recounted a story of teenagers seeking naloxone not for themselves, but to have on hand in case their parents overdosed—a stark illustration of the burden placed on the youngest generation.

Economic and Social Costs

The societal costs are immense. The crisis has been linked to declines in labor force participation and is estimated to cost the U.S. economy over $1 trillion annually in healthcare expenses, criminal justice costs, and lost productivity.

It is a public health emergency that is also a profound economic, social, and national security crisis.

Understanding the Tool’s Place in the Toolkit

While the direct operational impact of the opioid PHE was limited to specific actions, its symbolic and political impact was significant. HHS officials noted that the very act of declaring a nationwide PHE “underscores the urgency of ongoing federal, state, and local efforts.”

The declaration was a major news event that focused national attention on the crisis and helped frame it as a public health issue rather than a purely criminal one. In this way, the declaration’s value cannot be measured solely by the number of authorities invoked.

It served as a powerful signaling mechanism, elevating the opioid crisis to the highest level of national priority, catalyzing action, and providing political cover for agencies to dedicate resources to the problem.

The opioid crisis case study reveals that a Public Health Emergency declaration is neither a magic wand nor a meaningless gesture. It is a targeted legal tool with specific capabilities and inherent limitations.

For acute crises like pandemics or bioterror attacks, where the powers to rapidly deploy medical personnel, waive regulatory requirements, and mobilize emergency supplies are directly relevant, a PHE can be transformative.

For chronic, complex societal problems like addiction, poverty, or gun violence, the declaration serves more as a foundation for action than a solution itself. It provides regulatory flexibility, streamlines certain processes, and most importantly, signals national priority and commitment.

Understanding these distinctions is crucial for citizens evaluating their government’s response to health crises and for policymakers considering when and how to deploy this powerful but limited tool in America’s public health arsenal.

Our articles make government information more accessible. Please consult a qualified professional for financial, legal, or health advice specific to your circumstances.